Preparing your space
Preparing your space
Conditions & Recovery · Oncology Brothers · September 2, 2026
Welcome to the Oncology Brothers podcast! In this episode, we dived into the recent approval of rusfertide for polycythemia vera, based on the findings from the VERIFY study. We were joined by Dr. Andrew Kuykendall, an MPN specialist from the Moffitt Cancer Center, who shared insights on the drug's mechanism of action as a hepcidin mimetic and its clinical implications. Key topics discussed includ
Originally published by Oncology Brothers. We curate and add context; they did the reporting.
Read the full story at Oncology Brothers ↗